コーパス検索結果 (right1)
通し番号をクリックするとPubMedの該当ページを表示します
1 Consistent with the overall trial results, the rate of
the primary efficacy end point was 4.3% in the cangrelor grou
2 The rate of
the primary efficacy end point was 98.3% (95% CI, 96.1 to 99.
3 was the attenuation of accelerated telomere attrition, and
the primary efficacy end point was a 20% reduction in the ann
4 The primary efficacy end point was a composite of adjudicated
5 The primary efficacy end point was a composite of cardiovascu
6 The primary efficacy end point was a composite of death, myoc
7 The primary efficacy end point was a composite of recurrent n
8 The primary efficacy end point was absence of C. difficile-po
9 The primary efficacy end point was airflow decline-free survi
10 The primary efficacy end point was both an acceptable pacing
11 The primary efficacy end point was cGVHD response based on 20
12 The primary efficacy end point was change from baseline at we
13 The primary efficacy end point was change from baseline in to
14 The primary efficacy end point was change from baseline to da
15 The primary efficacy end point was change in Montgomery-Asber
16 The primary efficacy end point was change in resting myocardi
17 The primary efficacy end point was change in serum phosphate
18 The primary efficacy end point was clinically driven target-l
19 The primary efficacy end point was freedom from AF between 90
20 The primary efficacy end point was infarct size assessed by c
21 The primary efficacy end point was IOP in the study eye measu
22 The primary efficacy end point was mean change in serum potas
23 The primary efficacy end point was met by 71.2% versus 69.3%,
24 The primary efficacy end point was noninferiority of etelcalc
25 The primary efficacy end point was percentage change in splee
26 The primary efficacy end point was percentage of treatment re
27 The primary efficacy end point was primary patency of the tar
28 The primary efficacy end point was primary patency, defined a
29 The primary efficacy end point was sustained virologic respon
30 The primary efficacy end point was SVR12 (HCV RNA level below
31 The primary efficacy end point was target-vessel revasculariz
32 ndomly assigned to continue patiromer or switch to placebo;
the primary efficacy end point was the between-group differen
33 The primary efficacy end point was the change from baseline t
34 The primary efficacy end point was the change from baseline t
35 The primary efficacy end point was the composite of all-cause
36 The primary efficacy end point was the composite of cardiovas
37 The primary efficacy end point was the composite of death, my
38 The primary efficacy end point was the disappearance of the r
39 The primary efficacy end point was the median time to complet
40 The primary efficacy end point was the number of attacks of a
41 The primary efficacy end point was the number of hours of dir
42 The primary efficacy end point was the percentage of patients
43 The primary efficacy end point was the percentage of thrombus
44 The primary efficacy end point was the proportion of patients
45 The primary efficacy end point was the proportion of patients
46 The primary efficacy end point was the proportion of patients
47 The primary efficacy end point was the proportion of subjects
48 The primary efficacy end point was the rate of HIV type 1 (HI
49 The primary efficacy end point was the time to treatment fail
50 The primary efficacy end point was tumor response rate.
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。